Valuation: Haleon plc

Market Cap 32B 43.08B 37.45B 34.86B 60.43B 4,112B 61.37B 411B 161B 2,047B 162B 158B 6,865B P/E 2026 *
19.1x
P/E 2027 * 16.8x
Enterprise Value 38.87B 52.32B 45.48B 42.33B 73.4B 4,994B 74.53B 499B 196B 2,486B 196B 192B 8,337B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.23x
Free-Float
97.15%
Yield 2026 *
2.21%
Yield 2027 * 2.46%
1 day-1.44%
1 week-0.06%
1 month+3.65%
3 months+5.58%
6 months-4.12%
Current year-3.07%
1 week 362.7
Extreme 362.7
384.2
1 month 354.1
Extreme 354.1
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-0.06%-0.57%+10.09% 43.08B
-0.53%-3.95%+50.70%+153.56% 1,024B
+0.21%-2.68%+53.20%+51.79% 618B
-2.51%-3.25%+28.54%+68.94% 443B
+0.06%-0.42%+37.53%+30.67% 349B
-0.69%-0.30%+13.76%+12.83% 264B
-7.37%-4.40%-0.74%-44.28% 209B
-0.64%+2.43%+29.74%+65.93% 208B
-0.82%+0.70%+15.05%+72.05% 162B
+0.40%+1.92%+6.47%-29.77% 143B
Average -1.33%-1.10%+23.37%+39.18% 346.2B
Weighted average by Cap. -1.01%-1.99%+35.69%+71.13%

Financials

2026 *2027 *
Net sales 11.4B 15.35B 13.34B 12.42B 21.53B 1,465B 21.86B 146B 57.45B 729B 57.64B 56.37B 2,446B 11.89B 16B 13.91B 12.95B 22.45B 1,527B 22.8B 153B 59.9B 760B 60.09B 58.77B 2,550B
Net income 1.69B 2.27B 1.98B 1.84B 3.19B 217B 3.24B 21.69B 8.51B 108B 8.54B 8.35B 362B 1.92B 2.58B 2.25B 2.09B 3.63B 247B 3.68B 24.65B 9.67B 123B 9.71B 9.49B 412B
Net Debt 6.86B 9.24B 8.03B 7.48B 12.96B 882B 13.16B 88.11B 34.58B 439B 34.7B 33.93B 1,472B 6.39B 8.6B 7.48B 6.96B 12.07B 821B 12.26B 82.06B 32.21B 409B 32.31B 31.6B 1,371B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-07-31 GBX 363.30 -1.44% 25,724,593
26-07-30 GBX 368.60 -2.92% 27,282,182
26-07-29 GBX 379.70 -0.32% 36,335,259
26-07-28 GBX 380.90 +2.89% 29,790,922
26-07-27 GBX 370.20 +1.84% 24,375,691
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.633GBP
Average target price
4.166GBP
Spread / Average Target
+14.67%

Quarterly revenue - Rate of surprise